The Food and Drug Administration approved three lots of Chiron's flu vaccine Fluvirin for general distribution, easing fears of a possible vaccine shortage for the 2005 flu season. The approval means up to 1.5 million doses of Fluvirin will be shipped within the next few days. The Wall Street Journal ran a major story on a potential flu vaccine shortage Monday, which raised the possibility that supply problems could follow if Chiron was not able to deliver. Skeptics note that the company still lags far behind its competition and wonder if it will be able to come near its projected shipment of 15 million to 28 million doses.
- see this article from the San Jose Mercury News